These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Predictive factors for agitation severity of hyperactive delirium in terminally ill cancer patients in a general hospital using ordered logistic regression analysis. Kanbayashi Y, Hatano Y, Hata Y, Morita T, Fukui K, Hosokawa T. J Palliat Med; 2013 Sep; 16(9):1020-5. PubMed ID: 23888304 [Abstract] [Full Text] [Related]
7. Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan. Morita T, Chinone Y, Ikenaga M, Miyoshi M, Nakaho T, Nishitateno K, Sakonji M, Shima Y, Suenaga K, Takigawa C, Kohara H, Tani K, Kawamura Y, Matsubara T, Watanabe A, Yagi Y, Sasaki T, Higuchi A, Kimura H, Abo H, Ozawa T, Kizawa Y, Uchitomi Y, Japan Pain, Palliative Medicine, Rehabilitation, and Psycho-Oncology Study Group. J Pain Symptom Manage; 2005 Oct; 30(4):320-8. PubMed ID: 16256896 [Abstract] [Full Text] [Related]
12. Successful Management of Terminal Delirium With Transdermal Blonanserin Patch in a Terminally Ill Cancer Patient. Nishiofuku H, Mori M, Yokomichi N, Sakuma Y, Sugiyama K, Takashina Y, Miyagi A, Ishizuka M, Imai K, Morita T. J Palliat Med; 2024 Aug; 27(8):1097-1101. PubMed ID: 38335445 [Abstract] [Full Text] [Related]
14. Terminal delirium: families' experience. Namba M, Morita T, Imura C, Kiyohara E, Ishikawa S, Hirai K. Palliat Med; 2007 Oct; 21(7):587-94. PubMed ID: 17942497 [Abstract] [Full Text] [Related]
15. Sedation for delirium and other symptoms in terminally ill patients in Edmonton. Fainsinger RL, De Moissac D, Mancini I, Oneschuk D. J Palliat Care; 2000 Oct; 16(2):5-10. PubMed ID: 10887726 [Abstract] [Full Text] [Related]
16. High-dose neuroleptics and neuroleptic rotation for agitated delirium near the end of life. Bascom PB, Bordley JL, Lawton AJ. Am J Hosp Palliat Care; 2014 Dec; 31(8):808-11. PubMed ID: 24081790 [Abstract] [Full Text] [Related]
17. Delirium in terminal cancer: a prospective study using daily screening, early diagnosis, and continuous monitoring. Gagnon P, Allard P, Mâsse B, DeSerres M. J Pain Symptom Manage; 2000 Jun; 19(6):412-26. PubMed ID: 10908822 [Abstract] [Full Text] [Related]
19. Successful treatment of Wernicke encephalopathy in terminally ill cancer patients: report of 3 cases and review of the literature. Onishi H, Kawanishi C, Onose M, Yamada T, Saito H, Yoshida A, Noda K. Support Care Cancer; 2004 Aug; 12(8):604-8. PubMed ID: 15141340 [Abstract] [Full Text] [Related]
20. Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study. Elsayem A, Bush SH, Munsell MF, Curry E, Calderon BB, Paraskevopoulos T, Fadul N, Bruera E. J Pain Symptom Manage; 2010 Nov; 40(5):774-82. PubMed ID: 20728301 [Abstract] [Full Text] [Related] Page: [Next] [New Search]